Occurrence of invasive cancer after endoscopic treatment of Barrett's esophagus with high-grade dysplasia and intramucosal cancer in physiologically fit patients: time for a review of surveillance and treatment guidelines.
Digestive Diseases Center, University of Washington, Seattle, Washington, USA.
Adam
A
Templeton
Section of Gastroenterology and General and Thoracic Surgery, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.
Artur
A
Bodnar
Section of Gastroenterology and General and Thoracic Surgery, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.
S Ian
SI
Gan
Section of Gastroenterology and General and Thoracic Surgery, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.
Shayan
S
Irani
Section of Gastroenterology and General and Thoracic Surgery, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.
Andrew
A
Ross
Section of Gastroenterology and General and Thoracic Surgery, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington, USA.
Donald
D
Low
D000230:Adenocarcinoma / Q000473:pathology* / Q000628:therapy; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000473:pathology* / Q000601:surgery*; D017115:Catheter Ablation; D059186:Chemoradiotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000628:therapy; D016629:Esophagectomy; D004945:Esophagoscopy; D004947:Esophagus / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology / Q000601:surgery; D017410:Practice Guidelines as Topic; D057832:Watchful Waiting
D000970:Antineoplastic Agents